# Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism

> **NCT03629639** · PHASE4 · UNKNOWN · sponsor: **Central South University** · enrollment: 80 (estimated)

## Conditions studied

- Psoriasis Vulgaris With Metabolic Disorders

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03629639
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03629639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03629639, "Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT03629639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*